SEVERI, SILVIA
SEVERI, SILVIA
Dipartimento di Scienze mediche
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study
2021 Paganelli, G.; Sansovini, M.; Nicolini, S.; Grassi, I.; Ibrahim, T.; Amadori, E.; Di Iorio, V.; Monti, M.; Scarpi, E.; Bongiovanni, A.; Altini, M.; Urso, L.; Cittanti, C.; Matteucci, F.; Severi, S.
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients
2016 Feo, Carlo; Portinari, Mattia; Maestroni, Umberto; Del Rio, Paolo; Severi, Silvia; Viani, Lorenzo; Pravisani, Riccardo; Soliani, Giorgio; Zatelli, Maria Chiara; Ambrosio, Maria Rosaria; Tong, Jenny; Terrosu, Giovanni; Bresadola, Vittorio
Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients
2020 Paganelli, G.; Sarnelli, A.; Severi, S.; Sansovini, M.; Belli, M. L.; Monti, M.; Foca, F.; Celli, M.; Nicolini, S.; Tardelli, E.; Marini, I.; Matteucci, F.; Giganti, M.; Di Iorio, V.; De Giorgi, U.
Dosimetry for treatment with radiolabelled somatostatin analogues. A review
file con accesso da definire2010 Cremonesi, M.; Botta, F.; Di Dia, A.; Ferrari, M.; Bodei, L.; De Cicco, C.; Rossi, A.; Bartolomei, M.; Mei, R.; Severi, S.; Salvatori, M.; Pedroli, G.; Paganelli, G.
Financial aspects of sentinel lymph node biopsy in early breast cancer
file con accesso da definire2012 Severi, S.; Gazzoni, E.; Pellegrini, A.; Sansovini, M.; Raulli, G.; Corbelli, C.; Altini, M.; Paganelli, G.
Gene transcript analysis blood values correlate with 68Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status
2015 Bodei, L; Kidd, M.; Modlin, I. M.; Prasad, V.; Severi, Silvia; Ambrosini, V.; Kwekkeboom, D. J.; Krenning, E. P.; Baum, R. P.; Paganelli, Giovanni; Drozdov, I.
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study
2020 Strosberg, J.; Kunz, P. L.; Hendifar, A.; Yao, J.; Bushnell, D.; Kulke, M. H.; Baum, R. P.; Caplin, M.; Ruszniewski, P.; Delpassand, E.; Hobday, T.; Verslype, C.; Benson, A.; Srirajaskanthan, R.; Pavel, M.; Mora, J.; Berlin, J.; Grande, E.; Reed, N.; Seregni, E.; Paganelli, G.; Severi, S.; Morse, M.; Metz, D. C.; Ansquer, C.; Courbon, F.; Al-Nahhas, A.; Baudin, E.; Giammarile, F.; Taieb, D.; Mittra, E.; Wolin, E.; O'Dorisio, T. M.; Lebtahi, R.; Deroose, C. M.; Grana, C. M.; Bodei, L.; Oberg, K.; Polack, B. D.; He, B.; Mariani, M. F.; Gericke, G.; Santoro, P.; Erion, J. L.; Ravasi, L.; Krenning, E.
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors
2016 Bodei, L.; Kidd, M.; Modlin, I. M.; Severi, Silvia; Drozdov, I.; Nicolini, S.; Kwekkeboom, D. J.; Krenning, E. P.; Baum, R. P.; Paganelli, Giovanni
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest
2020 Bodei, L.; Kidd, M. S.; Singh, A.; van der Zwan, W. A.; Severi, S.; Drozdov, I. A.; Malczewska, A.; Baum, R. P.; Kwekkeboom, D. J.; Paganelli, G.; Krenning, E. P.; Modlin, I. M.
Spontaneous rupture of a hepatic epithelioid angiomyolipoma: damage control surgery. A case report
file con accesso da definire2013 Occhionorelli, Savino; Dellachiesa, Laura; Stano, Rocco; Cappellari, Lorenzo; Tartarini, Daniela; Severi, Silvia; Palini, Gian Marco; Pansini, Giancarlo; Vasquez, Giorgio
Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of 225Ac-PSMA (Prostate-Specific Membrane Antigen)
2020 Belli, M. L.; Sarnelli, A.; Mezzenga, E.; Cesarini, F.; Caroli, P.; Di Iorio, V.; Strigari, L.; Cremonesi, M.; Romeo, A.; Nicolini, S.; Matteucci, F.; Severi, S.; Paganelli, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study | 2021 | Paganelli, G.; Sansovini, M.; Nicolini, S.; Grassi, I.; Ibrahim, T.; Amadori, E.; Di Iorio, V.; M...onti, M.; Scarpi, E.; Bongiovanni, A.; Altini, M.; Urso, L.; Cittanti, C.; Matteucci, F.; Severi, S. | |
| Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients | 2016 | Feo, Carlo; Portinari, Mattia; Maestroni, Umberto; Del Rio, Paolo; Severi, Silvia; Viani, Lorenzo...; Pravisani, Riccardo; Soliani, Giorgio; Zatelli, Maria Chiara; Ambrosio, Maria Rosaria; Tong, Jenny; Terrosu, Giovanni; Bresadola, Vittorio | |
| Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients | 2020 | Paganelli, G.; Sarnelli, A.; Severi, S.; Sansovini, M.; Belli, M. L.; Monti, M.; Foca, F.; Celli,... M.; Nicolini, S.; Tardelli, E.; Marini, I.; Matteucci, F.; Giganti, M.; Di Iorio, V.; De Giorgi, U. | |
| Dosimetry for treatment with radiolabelled somatostatin analogues. A review | 2010 | Cremonesi, M.; Botta, F.; Di Dia, A.; Ferrari, M.; Bodei, L.; De Cicco, C.; Rossi, A.; Bartolomei..., M.; Mei, R.; Severi, S.; Salvatori, M.; Pedroli, G.; Paganelli, G. | file con accesso da definire |
| Financial aspects of sentinel lymph node biopsy in early breast cancer | 2012 | Severi, S.; Gazzoni, E.; Pellegrini, A.; Sansovini, M.; Raulli, G.; Corbelli, C.; Altini, M.; Pag...anelli, G. | file con accesso da definire |
| Gene transcript analysis blood values correlate with 68Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status | 2015 | Bodei, L; Kidd, M.; Modlin, I. M.; Prasad, V.; Severi, Silvia; Ambrosini, V.; Kwekkeboom, D. J.; ...Krenning, E. P.; Baum, R. P.; Paganelli, Giovanni; Drozdov, I. | |
| Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study | 2020 | Strosberg, J.; Kunz, P. L.; Hendifar, A.; Yao, J.; Bushnell, D.; Kulke, M. H.; Baum, R. P.; Capli...n, M.; Ruszniewski, P.; Delpassand, E.; Hobday, T.; Verslype, C.; Benson, A.; Srirajaskanthan, R.; Pavel, M.; Mora, J.; Berlin, J.; Grande, E.; Reed, N.; Seregni, E.; Paganelli, G.; Severi, S.; Morse, M.; Metz, D. C.; Ansquer, C.; Courbon, F.; Al-Nahhas, A.; Baudin, E.; Giammarile, F.; Taieb, D.; Mittra, E.; Wolin, E.; O'Dorisio, T. M.; Lebtahi, R.; Deroose, C. M.; Grana, C. M.; Bodei, L.; Oberg, K.; Polack, B. D.; He, B.; Mariani, M. F.; Gericke, G.; Santoro, P.; Erion, J. L.; Ravasi, L.; Krenning, E. | |
| Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors | 2016 | Bodei, L.; Kidd, M.; Modlin, I. M.; Severi, Silvia; Drozdov, I.; Nicolini, S.; Kwekkeboom, D. J.;... Krenning, E. P.; Baum, R. P.; Paganelli, Giovanni | |
| PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest | 2020 | Bodei, L.; Kidd, M. S.; Singh, A.; van der Zwan, W. A.; Severi, S.; Drozdov, I. A.; Malczewska, A....; Baum, R. P.; Kwekkeboom, D. J.; Paganelli, G.; Krenning, E. P.; Modlin, I. M. | |
| Spontaneous rupture of a hepatic epithelioid angiomyolipoma: damage control surgery. A case report | 2013 | Occhionorelli, Savino; Dellachiesa, Laura; Stano, Rocco; Cappellari, Lorenzo; Tartarini, Daniela;... Severi, Silvia; Palini, Gian Marco; Pansini, Giancarlo; Vasquez, Giorgio | file con accesso da definire |
| Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of 225Ac-PSMA (Prostate-Specific Membrane Antigen) | 2020 | Belli, M. L.; Sarnelli, A.; Mezzenga, E.; Cesarini, F.; Caroli, P.; Di Iorio, V.; Strigari, L.; C...remonesi, M.; Romeo, A.; Nicolini, S.; Matteucci, F.; Severi, S.; Paganelli, G. |